Advanced Practitioners in Oncology:
Earn Valuable CE Credits From Two Accredited Programs Today!

Learn From the Experts About Clinical Management of Novel Therapies for Hematologic Malignancies: Targeted Therapies, CAR-T, and Beyond

Risk-Adapted Treatment of Aggressive B-Cell Lymphomas: Application of Novel Agents
Risk-Adapted Treatment of Indolent B-Cell Lymphomas: Application of Novel Agents
Emerging Therapies for Multiple Myeloma
Emerging Therapies for Hodgkin Lymphoma
Risk-Adapted Treatment of Acute Myelogenous Leukemia
Risk-Adapted Treatment of Ph- Myeloproliferative Neoplasms

Learn From the Experts About Clinical Advances and Case Studies in Immune Checkpoint Inhibitors in Oncology

Overview of the Immune System and Immune Checkpoint Targets and their MOAs
Treatment-Related Issues
Management of Immune-Related Adverse Events
Renal Cell Carcinoma
Non–Small Cell Lung Cancer
Mismatch Repair Deficiency/Microsatellite Instability-High Cancers
Head and Neck Cancer
Urothelial Carcinoma
Learn Now Learn Now
Copyright © 2010-2021 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.